Barriers to implementing pharmacoeconomics: interview study

References

• Comprehensive assessment of Jordan’s health information system. World Health Organization. Regional Office for the Eastern Mediterranean. 2016 [cited 2020 Apr 25]. Available from: http://applications.emro.who.int/docs/9789290222583-eng.pdf?ua=1
   Google Scholar
• Fasseeh A, Karam R, Jameleddine M, et al. Implementation of health technology assessment in the Middle East and North Africa: comparison between the current and preferred status. Front Pharmacol. 2020;11:15.
   PubMed Web of Science ®Google Scholar
• Jordan High Health Council. Jordan National Health Account (NHA). The Technical Report No. 6, 2016. 2013 [cited 2020 Apr 25]. Available from: www.hhc.gov.jo
   Google Scholar
• Jordan Food and Drug Administration [homepage]. Amman (Jordan): The Administration; [cited 2020 Apr 25]. Available from: www.jfda.jo
   Google Scholar
• Hammad EA. The use of economic evidence to inform drug pricing decisions in Jordan. Value Health. 2016;19(2):233–238.
   PubMed Web of Science ®Google Scholar
• Al-Abbadi I, Qawwas A, Jaafreh M, et al. One-year assessment of joint procurement of pharmaceuticals in the public health sector in Jordan. Clin Ther. 2009;31(6):1335–1344.
   PubMed Web of Science ®Google Scholar
• Jordan National Drug Formulary (JNDF). JFDA. [Internet]. [cited 2020 Apr 25]. Available from: http://www.jfda.jo/EchoBusV3.0/SystemAssets/PDF/AR/JNDF-Book/JNDF%20V2%202011.pdf
   Google Scholar
• Dilokthornsakul P, Thomas D, Brown L, et al. Interpreting pharmacoeconomic findings. Clinical pharmacy education, practice and research. Amsterdam, The Netherlands: Elsevier; ‏2018: 277–287.
   Google Scholar
• Alefan Q, Ibrahim MIM, Razak TA, et al. The impact of poorly controlled hypertension on ambulatory care resources in Malaysia. JCDR. 2010;4(6):3371–3377.
   Google Scholar
• Drummond M, Schulpher M, Claxton K, et al. Methods for the economic appraisal of health care programmes. 4th ed. Oxford: Oxford University Press; 2015.
   Google Scholar
• Alefan Q, Alshareef S, Al-Shatnawi S. Drug and therapeutics committees in Jordanian hospitals: a nation-wide survey of organization, activities, and drug selection procedures. Pharm Pract (Granada). 2019;17(4):1590.
   PubMed Web of Science ®Google Scholar
• Haddix AC, Teutsch SM, CORSO PS. Prevention effectiveness: a guide to decision analysis and economic evaluation. New York: Oxford University Press; 2002.
   Google Scholar
• Freund DA, Dittus RS. Principles of pharmacoeconomic analysis of drug therapy. PharmacoEconomics. 1992;1(1):20–32.
   PubMedGoogle Scholar
• Greenberg PE, Arcelus A, Birnbaum HG, et al. Pharmacoeconomics and health policy. Current applications and prospects for the future. Pharmacoeconomics. 1999;16(5 Pt 1):425–432.
   PubMed Web of Science ®Google Scholar
• Williams I, Bryan S. Understanding the limited impact of economic evaluation in health care resource allocation: a conceptual framework. Health Policy. 2007;80(1):135–143.
   PubMed Web of Science ®Google Scholar
• UK/US Purchasers’ Group. Better information, better outcomes: the use of health technology assessment and clinical effectiveness data in health care purchasing decisions in the UK and the United States. New York: Millbank Memorial Fund; 2000.
   Google Scholar
• Gutiérrez H, Nelson H, Becerra S. et al. The assessment of pharmacoeconomic studies quality of Levodopa’s use for the management of Parkinson’s diseases, 2010–2015. Rev Colomb Cienc Quim Farm. 2017;46(2):256–277.
   Google Scholar
• Walkom E, Robertson J, Newby D, et al. The role of pharmacoeconomics in formulary decision-making. Formulary. 2006;41:374–386.
   Google Scholar
• Ross J. The use of economic evaluation in health care: Australian decision makers’ perceptions. Health Policy. 1995;31(2):103–110.
   PubMed Web of Science ®Google Scholar
• Mori A, Gavaza P, Robberstad B. Role of pharmacoeconomics in developing countries. Farmeconomia health economics and therapeutic pathways. 2013;14(1):3–5.
   Google Scholar
• Lafi R, Robinson S, Williams I. Economic evaluation and the Jordan rational drug list: an exploratory study of national-level priority setting. Value Health. 2012;15(5):771–776.
   PubMed Web of Science ®Google Scholar
• Ritchie J, Lewis J, Nicholls CM, et al. Qualitative research practice: A guide for social science students and researchers. 2nd ed. LA: SAGE Publications Ltd; 2013.
   Google Scholar
• Sample Size MM. Saturation in PhD studies using qualitative interviews. Forum qualitative Sozialforschung/Forum: qualitative social research. 2010;11.
   Google Scholar
• McGrath C, Palmgren PJ, Liljedahl M. Twelve tips for conducting qualitative research interviews. Med Teach. 2019;41(9):1002–1006.
   PubMed Web of Science ®Google Scholar
• Tarn YH, Hu S, Kamae I, et al. Health-care systems and pharmacoeconomic research in Asia-Pacific region. Value Health. 2008 Mar 1;11:S137–SS155.
   PubMed Web of Science ®Google Scholar
• Majid MA, Othman M, Mohamad SF, et al. Piloting for interviews in qualitative research: operationalization and lessons learnt. Int J Acad Res Bus Soc Sci. 2017;7(4):1073–1080.
   Google Scholar
• Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
   Google Scholar
• Harris A, Buxton M, O’Brien B, et al. Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries. Expert Rev Pharm Out. 2001;1(1):7–12.
   Google Scholar
• Odedina FT, Sullivan J, Nash R, et al. Use of pharmacoeconomic data in making hospital formulary decisions. Am J Health-syst Pharm. 2002;59(15):1441–1444.
   PubMed Web of Science ®Google Scholar
• H-M S, Charavel M, Morelle M, et al. A qualitative approach to the use of economic data in the selection of medicines for hospital formularies: a French survey. Pharm World Sci. 2003;25(6):269–275.
   PubMedGoogle Scholar
• Walkom E, Robertson J, Newby D, et al. The role of pharmacoeconomics in formulary decision-making. Formulary. 2006 Aug 1;41(8).
   Google Scholar
• Jordan Food and Drug Administration. Jordan. JFDA. 2016. [cited 2020 Apr 25]. Available from: http://www.jfda.jo/Pages/viewpage.aspx?pageID=153
   Google Scholar
• Alsultan MS. The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia. Saudi Pharm J. 2011;19(1):51–56.
   PubMed Web of Science ®Google Scholar
• Zwart-van Rijkom JEF, Leufkens HGM, Busschbach JJV, et al. Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. Pharmacoeconomics. 2000;18(2):149–160.
   PubMed Web of Science ®Google Scholar
• Fattore G, Torbica A. Economic evaluation in health care: the point of view of informed physicians. Value Health. 2006;9(3):157–167.
   PubMed Web of Science ®Google Scholar
• Arenas‐Guzman R, Tosti A, Hay R, et al. Pharmacoeconomics–an aid to better decision‐making. J Eur Acad Dermatol Venereol. 2005;19(s1):34–39.
   PubMedGoogle Scholar
• Nishimura S, Torrance GW, Ikegami N, et al. Information barriers to the implementation of economic evaluations in Japan. Pharmacoeconomics. 2002;20(2):9–15.
   PubMedGoogle Scholar
• Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med. 2007;4(9):e283.
   PubMed Web of Science ®Google Scholar
• Piloting the development of an evidence-based care pathway: pharmacological treatment of adults with essential hypertension in a primary care setting in Jordan. [Internet]. UK. National Institute for Health and Clinical Excellence. 2009. [cited 2020 Apr 25]. Available from: http://www.idsihealth.org/wp-content/uploads/2016/09/Jordan-Pilot-evidence-care-pathway.pdf
   Google Scholar
• Newgard CD, Zive D, Jui J, et al. Electronic versus manual data processing: evaluating the use of electronic health records in out-of-hospital clinical research. Acad Emerg Med. 2012;19(2):217–227.
   PubMed Web of Science ®Google Scholar
• Eisenstein EL, Collins R, Cracknell BS, et al. Sensible approaches for reducing clinical trial costs. Clin Trials. 2008;5(1):75–84.
   PubMed Web of Science ®Google Scholar
• Yip A, Leduc M, Teo V, et al. A novel method to link and validate routinely collected emergency department clinical data to measure quality of care. Am J Med Qual. 2009;24(3):185–191.
   PubMed Web of Science ®Google Scholar
• Pavlovic I, Kern T, Miklavcic D. Comparison of paper-based and electronic data collection process in clinical trials: costs simulation study. Contemp Clin Trials. 2009;30(4):300–316.
   PubMed Web of Science ®Google Scholar
• Nahm ML, Pieper CF, Cunningham MM. Quantifying data quality for clinical trials using electronic data capture. PloS One. 2008 Aug;3(8):e3049.
   PubMed Web of Science ®Google Scholar
• Nassar DA, Othman M, Hayajneh JA, et al. An integrated success model for an electronic health record: a case study of Hakeem Jordan. Procedia Econ. 2015;23:95–103.
   Google Scholar
• Alefan Q, Rascati K. Pharmacoeconomic studies in World Health Organization Eastern Mediterranean countries: reporting completeness. Int J Technol Assess Health Care. 2017;33(2):215–221.
   PubMed Web of Science ®Google Scholar
• Choi SE. Current state and challenges of pharmacoeconomic evaluation in Korea. J Prev Med Public Health. 2008;41(2):74–79.
   PubMedGoogle Scholar
• Bodrogi J, Kaló Z. Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development. Br J Pharmacol. 2010;159(7):1367–1373.
   PubMed Web of Science ®Google Scholar
• Bentkover J, Corey R. Effective utilization of pharmacoeconomics for decision makers. Dis Manage Health Outcomes. 2002;10(2):75–80.
   Google Scholar
• Catić T, Skrbo S. Pharmacoeconomic education for pharmacy students in Bosnia and Herzegovina. Mater Sociomed. 2013;25(4):282–285.
   PubMedGoogle Scholar
• Al Aqeel SA, Al-Sultan M. The use of pharmacoeconomic evidence to support formulary decision making in Saudi Arabia: methodological recommendations. Saudi Pharm J. 2012;20(3):187–194.
   PubMed Web of Science ®Google Scholar
• Yim EY, Lim SH, Oh MJ, et al. Assessment of pharmacoeconomic evaluations submitted for reimbursement in Korea. Value Health. 2012;15(1):S104–S110.
   PubMed Web of Science ®Google Scholar
• Alefan Q, AlImam S, Mukattash T, et al. Pharmacoeconomics education in WHO Eastern Mediterranean region. Curr Pharm Teach Learn. 2015;7(6):819–825.
   Web of Science ®Google Scholar
• Pharmacoeconomic guidelines around the world. [online]. [cited 2020 Apr 25]. Available at: https://tools.ispor.org/peguidelines/
   Google Scholar